Does RUXOLITINIB Cause Platelet count abnormal? 786 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 786 reports of Platelet count abnormal have been filed in association with RUXOLITINIB (OPZELURA). This represents 1.2% of all adverse event reports for RUXOLITINIB.
786
Reports of Platelet count abnormal with RUXOLITINIB
1.2%
of all RUXOLITINIB reports
27
Deaths
110
Hospitalizations
How Dangerous Is Platelet count abnormal From RUXOLITINIB?
Of the 786 reports, 27 (3.4%) resulted in death, 110 (14.0%) required hospitalization, and 9 (1.1%) were considered life-threatening.
Is Platelet count abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 786 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Platelet count abnormal?
ROMIPLOSTIM (703)
ELTROMBOPAG OLAMINE (370)
ECULIZUMAB (261)
LENALIDOMIDE (216)
RITUXIMAB (181)
VENETOCLAX (178)
IBRUTINIB (176)
DEXAMETHASONE (128)
NIRAPARIB (112)
ELTROMBOPAG (106)
Which RUXOLITINIB Alternatives Have Lower Platelet count abnormal Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE